BACKGROUND: The recent development of a large panel of genome-wide single nucleotide polymorphisms (SNPs) provides the opportunity to examine genetic relationships between distinct SHR lines that share hypertension but differ in their susceptibility to hypertensive end-organ disease. METHODS AND RESULTS: We compared genotypes at nearly 10,000 SNPs obtained for the hypertension end-organ injury-susceptible spontaneously hypertensive rat (SHR)-A3 (SHRSP, SHR-stroke prone) line and the injury-resistant SHR-B2 line. This revealed that that the 2 lines were genetically identical by descent (IBD) across 86.6% of the genome. Areas of the genome that were not IBD were distributed across 19 of the 20 autosomes and the X chromosome. A block structure of non-IBD comprising a total of 121 haplotype blocks was formed by clustering of SNPs inherited from different ancestors. To test the null hypothesis that distinct SHR lines share a common set of hypertension susceptibility alleles, we compared blood pressure in adult SHR animals from both lines and their F1 and F2 progeny using telemetry. In 16- to 18-week-old animals fed a normal diet, systolic blood pressure (SBP, mm Hg) in SHR-A3 was 205.7 ± 3.86 (mean ± SEM, n = 26), whereas in similar SHR-B2 animals, SBP was 186.7 ± 2.53 (n = 20). In F1 and F2 animals, SBP was 188.2 ± 4.23 (n = 19) and 185.6 ± 1.1 (n = 211), respectively (P<10(-6), ANOVA). To identify non-IBD haplotype blocks contributing to blood pressure differences between these SHR lines, we developed a high-throughput SNP genotyping system to genotype SNPs marking non-IBD blocks. We mapped a single non-IBD block on chromosome 17 extending over <10 Mb, at which SHR-A3 alleles significantly elevate blood pressure compared with SHR-B2. CONCLUSIONS: Thus hypertension in SHR-A3 and -B2 appears to arise from an overlapping set of susceptibility alleles, with SHR-A3 possessing an additional hypertension locus that contributes to further increase blood pressure.
BACKGROUND: The recent development of a large panel of genome-wide single nucleotide polymorphisms (SNPs) provides the opportunity to examine genetic relationships between distinct SHR lines that share hypertension but differ in their susceptibility to hypertensive end-organ disease. METHODS AND RESULTS: We compared genotypes at nearly 10,000 SNPs obtained for the hypertension end-organ injury-susceptible spontaneously hypertensiverat (SHR)-A3 (SHRSP, SHR-stroke prone) line and the injury-resistant SHR-B2 line. This revealed that that the 2 lines were genetically identical by descent (IBD) across 86.6% of the genome. Areas of the genome that were not IBD were distributed across 19 of the 20 autosomes and the X chromosome. A block structure of non-IBD comprising a total of 121 haplotype blocks was formed by clustering of SNPs inherited from different ancestors. To test the null hypothesis that distinct SHR lines share a common set of hypertension susceptibility alleles, we compared blood pressure in adult SHR animals from both lines and their F1 and F2 progeny using telemetry. In 16- to 18-week-old animals fed a normal diet, systolic blood pressure (SBP, mm Hg) in SHR-A3 was 205.7 ± 3.86 (mean ± SEM, n = 26), whereas in similar SHR-B2 animals, SBP was 186.7 ± 2.53 (n = 20). In F1 and F2 animals, SBP was 188.2 ± 4.23 (n = 19) and 185.6 ± 1.1 (n = 211), respectively (P<10(-6), ANOVA). To identify non-IBD haplotype blocks contributing to blood pressure differences between these SHR lines, we developed a high-throughput SNP genotyping system to genotype SNPs marking non-IBD blocks. We mapped a single non-IBD block on chromosome 17 extending over <10 Mb, at which SHR-A3 alleles significantly elevate blood pressure compared with SHR-B2. CONCLUSIONS: Thus hypertension in SHR-A3 and -B2 appears to arise from an overlapping set of susceptibility alleles, with SHR-A3 possessing an additional hypertension locus that contributes to further increase blood pressure.
Authors: Michal Pravenec; Paul C Churchill; Monique C Churchill; Ondrej Viklicky; Ludmila Kazdova; Timothy J Aitman; Enrico Petretto; Norbert Hubner; Caroline A Wallace; Heike Zimdahl; Vaclav Zidek; Vladimir Landa; Joseph Dunbar; Anil Bidani; Karen Griffin; Nathan Qi; Martina Maxova; Vladimir Kren; Petr Mlejnek; Jiaming Wang; Theodore W Kurtz Journal: Nat Genet Date: 2008-06-29 Impact factor: 38.330
Authors: H J Jacob; K Lindpaintner; S E Lincoln; K Kusumi; R K Bunker; Y P Mao; D Ganten; V J Dzau; E S Lander Journal: Cell Date: 1991-10-04 Impact factor: 41.582
Authors: P Hilbert; K Lindpaintner; J S Beckmann; T Serikawa; F Soubrier; C Dubay; P Cartwright; B De Gouyon; C Julier; S Takahasi Journal: Nature Date: 1991-10-10 Impact factor: 49.962
Authors: Renata I Dmitrieva; Cruz A Hinojos; Eric Boerwinkle; Michael C Braun; Myriam Fornage; Peter A Doris Journal: Hypertension Date: 2008-04-28 Impact factor: 10.190
Authors: F E Albrecht; J Drago; R A Felder; M P Printz; G M Eisner; J E Robillard; D R Sibley; H J Westphal; P A Jose Journal: J Clin Invest Date: 1996-05-15 Impact factor: 14.808
Authors: Michael C Braun; Stacy M Herring; Nisha Gokul; Monique Monita; Rebecca Bell; Yaming Zhu; Manuel L Gonzalez-Garay; Scott E Wenderfer; Peter A Doris Journal: Circ Cardiovasc Genet Date: 2014-11-03
Authors: Isha S Dhande; Stacy M Cranford; Yaming Zhu; Sterling C Kneedler; M John Hicks; Scott E Wenderfer; Michael C Braun; Peter A Doris Journal: Hypertension Date: 2018-02-05 Impact factor: 10.190
Authors: Isha S Dhande; Sterling C Kneedler; Aniket S Joshi; Yaming Zhu; M John Hicks; Scott E Wenderfer; Michael C Braun; Peter A Doris Journal: Physiol Genomics Date: 2019-10-14 Impact factor: 3.107
Authors: Isha S Dhande; Yaming Zhu; Michael C Braun; M John Hicks; Scott E Wenderfer; Peter A Doris Journal: Physiol Genomics Date: 2016-12-23 Impact factor: 3.107
Authors: Sterling C Kneedler; Lauren E Phillips; Kayla R Hudson; Katharine M Beckman; Catalina A Lopez Gelston; Joseph M Rutkowski; Alan R Parrish; Peter A Doris; Brett M Mitchell Journal: Am J Physiol Renal Physiol Date: 2017-02-22
Authors: Mykola Mamenko; Isha Dhande; Viktor Tomilin; Oleg Zaika; Nabila Boukelmoune; Yaming Zhu; Manuel L Gonzalez-Garay; Oleh Pochynyuk; Peter A Doris Journal: J Am Soc Nephrol Date: 2015-11-16 Impact factor: 10.121
Authors: Michael C Braun; Stacy M Herring; Nisha Gokul; Monique Monita; Rebecca Bell; M John Hicks; Scott E Wenderfer; Peter A Doris Journal: J Hypertens Date: 2013-10 Impact factor: 4.844